GlassScriptPhysician profile
Brett Odum
NPI 1336143163
$4,669.66
in general payments reported to CMS, 2019-2025
42 companies · $912 in 2025
The $912 reported for 2025 was more than what 84% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $236 · 2020: $408 · 2021: $942 · 2022: $789 · 2023: $702 · 2024: $681 · 2025: $912.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,251 · Education: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,250.85 |
| Education | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $881.49 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $759.02 | 2020-2025 | |
| Glaxosmithkline, LLC. | $666.93 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Astrazeneca Pharmaceuticals LP | $436.05 | 2020-2025 | Breztri, Farxiga |
| Astellas Pharma US INC | $367.99 | 2019-2025 | Veozah, Myrbetriq |
| Lilly USA, LLC | $198.32 | 2020-2025 | Zepbound, Mounjaro, Jardiance |
| Lundbeck LLC | $120.81 | 2020-2025 | Vyepti |
| Corium, LLC | $94.72 | 2023-2025 | Azstarys, Adlarity |
| Axsome Therapeutics, INC. | $77.83 | 2022-2025 | Auvelity |
| Novartis Pharmaceuticals Corporation | $75.86 | 2021-2025 | |
| Allergan, INC. | $74.47 | 2020-2021 | |
| Dexcom, INC. | $57.18 | 2021-2023 | Dexcom G6 Transmitter |
| Pfizer INC. | $55.42 | 2022-2025 | |
| Amgen INC. | $53.14 | 2019-2023 | Otezla, Repatha |
| Boston Scientific Corporation | $52.65 | 2025 | General - Erectile Dysfunction |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brett Odum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.